173 related articles for article (PubMed ID: 15854985)
1. Iris metastasis of esophageal cancer.
Ichiki Y; Morita M; Yano K; Sugio K; Yasumoto K; Hirose N
Ann Thorac Surg; 2005 May; 79(5):1782-4. PubMed ID: 15854985
[TBL] [Abstract][Full Text] [Related]
2. [Case with metastasis of a squamous esophageal cancer of the iris with resemblance to hypopyon].
Kiuchi K; Kimoto T; Takahashi K; Shima C; Nishimura T; Matsumura M
Nippon Ganka Gakkai Zasshi; 2007 Sep; 111(9):735-40. PubMed ID: 17907468
[TBL] [Abstract][Full Text] [Related]
3. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
[TBL] [Abstract][Full Text] [Related]
5. Metastatic esophageal adenocarcinoma presenting in the iris.
Lee WB; Sy HM; Filip DJ; Grossniklaus HE
Am J Ophthalmol; 2007 Sep; 144(3):477-9. PubMed ID: 17765442
[TBL] [Abstract][Full Text] [Related]
6. Unusual iris metastasis from anal cancer: a case report.
Tougeron D; Tougeron-Brousseau B; Nasser Z; Benzerroug M; Lefebure B; Hamidou H; Michel P; Muraine M
Dig Liver Dis; 2009 Jul; 41(7):e1-3. PubMed ID: 18294934
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
8. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
[TBL] [Abstract][Full Text] [Related]
11. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S;
Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565
[TBL] [Abstract][Full Text] [Related]
12. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
13. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results.
de Manzoni G; Pedrazzani C; Laterza E; Pasini F; Grandinetti A; Bernini M; Ruzzenente A; Zerman G; Tomezzoli A; Cordiano C
Ann Thorac Surg; 2005 Oct; 80(4):1176-83. PubMed ID: 16181836
[TBL] [Abstract][Full Text] [Related]
14. [Metastasis of an esophageal carcinoma at a PEG site--case report and review of the literature].
Volkmer K; Meyer T; Sailer M; Fein M
Zentralbl Chir; 2009 Sep; 134(5):481-5. PubMed ID: 19757350
[TBL] [Abstract][Full Text] [Related]
15. [A case of squamous cell carcinoma of esophagus with mediastinal lymph node recurrence after surgical resection treated with systemic chemotherapy and chemoradiotherapy].
Matsuyama J; Fukushima Y; Hashimoto K; Morita S; Morimoto T; Nishishou I; Sasaki Y
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1991-2. PubMed ID: 18219875
[TBL] [Abstract][Full Text] [Related]
16. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
[TBL] [Abstract][Full Text] [Related]
17. [The role of radiation therapy in the management of esophageal cancer: an analysis on surgically resected cases].
Okazaki A; Matsuura M; Saito A; Shin S; Takasu S
Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):665-72. PubMed ID: 3404018
[No Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
